Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

  • Chief medical officer warns antibiotic resistance could signal 'end of modern medicine'

    England’s chief medical officer Sally Davies has warned that if antibiotics lose their effectiveness it would spell “the end of modern medicine”.

    Speaking at a United Nations Interagency Coordination Group (IACG) on Antimicrobial Resistance conference organised by the Wellcome Trust in partnership with the UK, Ghanaian and Thai governments in Berlin, Davies warned that unless action was taken on antimicrobial stewardship the world was facing a “post-antibiotic apocalypse”.

    She estimated that about one in three or one in four prescriptions in UK primary care were probably not needed.

    In September 2017 the RPS launched a major new campaign calling on all pharmacists to play a greater role in safeguarding antibiotics and minimising the spread of antimicrobial resistance.

  • Rebalancing Board chair acknowledges pharmacists' 'considerable fears' around supervision

    The pharmacy Rebalancing Board has no plans to add to its membership nor make changes to the way that it is looking at the supervision issue, the chair of the board, Ken Jarrold, has told The Pharmaceutical Journal in an exclusive interview.

    But Jarrold, a health service manager, said he would welcome input from the Pharmacists’ Defence Association (PDA), which in October 2017 announced plans to launch a campaign to ‘reclaim the supervision debate’ from the Rebalancing Board.

    Jarrold accepted that the work on supervision was progressing slowly, but said that this was partly due to factors outside of the board’s control disrupting its work, including two general elections.

    “We are also taking time to consider issues carefully and thoughtfully, including supporting quality systems, and we’re listening to all those involved,” he said.

    Jarrold acknowledged that the issue of supervision aroused “considerable fears” from pharmacists. “Supervision is a very sensitive issue because it comes to the heart of what pharmacists feel about themselves and about the future, and that is why we have got to approach it carefully,” he said. “We recognise, understand and respect that, and that is why it is important that we get this right.”

    Members of the Rebalancing Board did hold very differing views on supervision and how it should change, Jarrold confirmed. “That’s why we have taken time to stand back and consider all the issues, including supporting quality systems that will have to be considered around any changes that might be made in supervision.

    ”We do believe that we have been and are approaching our work conscientiously and inclusively. It is more important to get the sensitive and difficult issues right than it is to speed up, and we want to go on listening carefully to every member of the board. When we have proposals, we will take them to the partners’ forum, and we will continue to be transparent as we have always tried to be.”

    The group, known formally as the ‘Rebalancing Medicines Legislation and Pharmacy Regulation Programme Board’ was asked to look at informing a more modern, risk-based regulatory approach to pharmacy that maintained safety, built in quality and maximised the skills of pharmacists and pharmacy technicians. It was also asked to address those aspects of professional regulation that impeded the deployment of modern technologies and put disproportionate or unnecessary obstacles in the way of new models of service delivery.

    In September, a leaked document, prepared by a working group of the rebalancing board suggested that current legislation could be changed to allow a ‘registered pharmacy professional’, which could include a pharmacy technician, to ‘take responsibility for’ the sale and supply of pharmacy and prescription-only medicines.

    The rebalancing board currently includes representatives of the Royal Pharmaceutical Society (RPS) and General Pharmaceutical Council along with all four chief pharmaceutical officers, a representative from the Medicines and Healthcare products Regulatory Agency and other pharmacy stakeholders. It does not include representatives from the PDA or the National Pharmacy Association (NPA), and there are no plans to change this.

dame-sally-davies-chief-medical-officer-15

Chief medical officer warns antibiotic resistance could signal 'end of modern medicine'

England’s chief medical officer Sally Davies has warned that if antibiotics lose their effectiveness it would spell “the end of modern medicine”.

Speaking at a United Nations Interagency Coordination Group (IACG) on Antimicrobial Resistance conference organised by the Wellcome Trust in partnership with the UK, Ghanaian and Thai governments in Berlin, Davies warned that unless action was taken on antimicrobial stewardship the world was facing a “post-antibiotic apocalypse”.

She estimated that about one in three or one in four prescriptions in UK primary care were probably not needed.

In September 2017 the RPS launched a major new campaign calling on all pharmacists to play a greater role in safeguarding antibiotics and minimising the spread of antimicrobial resistance.

  • pause slideshow

mark koziol Pharmacists’ Defence Association chairman

Rebalancing Board asked to adopt patient safety 'pledge'

The Department of Health’s Rebalancing Board is being urged to adopt a patient safety “pledge” by two bodies representing community pharmacists.

deep-vein-thrombosis-dvt-in-leg

Newer anticoagulants have no more safety risks than warfarin

Treating venous thromboembolism with direct oral anticoagulants creates no greater risk of major bleeding or death in the first 90 days of treatment compared with warfarin.

robbie turner

State-backed indemnity scheme for GPs to cover wider practice staff

The Department of Health is planning a new state-backed indemnity scheme for general practice in England, Jeremy Hunt, secretary of state for health, announced on 12 October.

veterinary medicine

Sales of veterinary antibiotics fall across Europe

The sales of veterinary antibiotics are declining in most countries in Europe, a report from the European Medicines Agency (EMA) has found.

Simon Stevens ss Oct 17

Public Health England to consider removing travel vaccinations from NHS prescriptions

A review by Public Health England (PHE) on whether travel vaccinations should be removed from NHS prescriptions has been requested by the chief executive of NHS England.

Parliament buildings

Drugs taking too long to be prescribed after NICE approval, pharma firms warn

Medicines approved for use in the NHS are taking too long to be prescribed to patients, major pharmaceutical firms have told a House of Lords committee.

cannabis plant

World Medical Association says laws on cannabis research should be reviewed

The World Medical Association (WMA) has called for laws governing research-grade cannabis to be reviewed to allow more research on using cannabis for medicinal purposes.

All News

pregnant lady

House of Commons to discuss the use of valproate in pregnancy

The UK Parliament is to hold a debate on the use of epilepsy drug valproate in pregnancy on 19 October 2017, after campaigners and MPs called for a discussion on the drug’s risk.

scientists conducting analysis in laboratory

Independent review outlines how UK can retain success in life sciences

An independent review of the life sciences industry in the UK has highlighted how the UK can exploit its existing strength to increase the pace of economic growth in the sector.

All United Kingdom

Peanuts

Combined oral immunotherapy shows lasting effect against peanut allergy four years laterSubscription

In a report of the long-term outcomes of probiotics plus peanut oral immunotherapy, more than half of study participants were able to continue eating peanuts up to four years later.

Pre-exposure prophylaxis (PrEP) pills spilling from Truvada bottle

HIV PrEP needs licensing for adolescents, researchers saySubscription

Study highlights a need for adolescent men who have sex with men to be given pre-exposure prophylaxis and for adherence to be promoted in this group.

Knee operation

Limit opioid use before knee surgery to optimise outcomes, say researchersSubscription

Study supports existing research that preoperative opioid use could lead to worse pain outcomes after surgery.

Transcranial direct current stimulation exercise

Brain stimulation not as effective as drugs for depressionSubscription

In a placebo-controlled trial, transcranial direct-current stimulation did not show non-inferiority compared with escitalopram and was associated with more adverse events.

Ibuprofen and paracetamol packets

Ibuprofen raises blood pressure more than celecoxibSubscription

Study investigated the link between non-steroidal anti-inflammatory drugs and raised blood pressure and heart problems in patients who either had, or were at increased risk, of coronary artery disease. 

Senior person holding a lit cigarette

Older smokers more likely to become frail than non-smokersSubscription

Study shows that current smokers, aged 60 years or older, had a 60% greater odds of becoming frail during follow-up compared with non-smokers.

Polarised light micrograph of serotonin crystals

Atypical antipsychotic causes weight gain by targeting serotonin receptor 2CSubscription

Study suggests that serotonin 2C receptor agonists may be useful in preventing metabolic side effects associated with taking atypical antipsychotics.

Urine in test tube

New test determines antibiotic susceptibility in less than 30 minutesSubscription

A diagnostic test for urinary tract infections, that affect 100 million women annually, could be valuable in the fight against antimicrobial resistance.

All Science

Special report

RPS annual conference 2017

The 2017 RPS Annual Conference (3–4 September 2017 at the The Vox, Birmingham) focuses on the reality of healthcare change; health challenges of our time; career development and progression; and learning.

Read more

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.

Pharmaceutical Journal Jobs

More jobs